New gene therapy strategies emerging to combat vision loss

Diseases of the eye that cause vision loss and blindness, especially neurodegenerative disorders affecting the retina, are ideal targets for gene therapy, including gene replacement and promising corrective gene editing strategies. A comprehensive Review article providing an overview of emerging therapeutic approaches and innovative gene delivery and gene editing tools to treat ocular diseases is published in Human Gene Therapy.

Lolita Petit, Hemant Khanna, and Claudio Punzo, University of Massachusetts Medical School, Worcester, coauthored the article "Advances in Gene Therapy for Diseases of the Eye." They provide insights on recent progress in clinical applications of retinal therapy, preclinical advances in gene-specific therapy for photoreceptor diseases, and the development of gene independent therapeutic strategies.

"The spectacular successes of for eye diseases may be seen as providing a platform for molecular approaches to a much broader range of disorders affecting vision," says Editor-in-Chief Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Medical School, Worcester, MA.


Explore further

Update on advances in gene therapy from National Center for Advancing Translational Sciences

More information: Lolita Petit et al, Advances in Gene Therapy for Diseases of the Eye, Human Gene Therapy (2016). DOI: 10.1089/hum.2016.040
Journal information: Human Gene Therapy

Citation: New gene therapy strategies emerging to combat vision loss (2016, June 22) retrieved 19 January 2020 from https://medicalxpress.com/news/2016-06-gene-therapy-strategies-emerging-combat.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
17 shares

Feedback to editors

User comments